We are delighted to announce our participation in CPHI Frankfurt 2025. This is a fantastic opportunity to connect, collaborate, and explore new possibilities together.
If you would like to schedule a meeting with us, please do so now by filling out the form at the bottom of this page. We look forward to seeing you there!
Modified Phosphoramidites
We are thrilled to announce that Summit Pharmaceuticals Europe is now promoting new modified nucleic acids (phosphoramidites) from Luxna Biotech Co., Ltd.(“Luxna”), a leading biotech company in Japan specializing in the research and development of oligonucleotide therapeutics.
DAIB (Diacetoxyiodo)benzene (CAS 3240-34-4) / DAIM (Diacetoxyiodo)mesitylene (CAS 33035-41-5)
Low-toxic versatile oxidizing agents based on hypervalent iodine. DAIM is particularly suited for use with low-polar solvents.
D-Epoxone (CAS 18422-53-2)
Asymmetric epoxidation catalyst for the production of chiral epoxides. High-purity, heavy metal-free. Eco-friendly production process.
Buchwald Phosphine Ligands
Highly-effective ligands for Pd-catalyzed cross-coupling reactions.
Personal Care Dept. transferred to SACI-CFPA to complete the Sumitomo Corporation’s Cosmetic European Integration Project.
December 2020
Summit Pharmaceuticals Europe Limited (in UK) merged into new Summit Pharmaceuticals Europe S.r.l. (in Italy). 100% owned by Summit Pharmaceuticals International.
May 2015
Opened Düsseldorf Branch, Personal Care Dept., by acquiring cosmetic ingredient distribution business from Kyowa Hakko Europe GmbH.
April 2012
Changed share holding. Now Sumitomo Corporation Japan has 50%, Sumitomo Corporation Europe 30% and Summit Pharmaceuticals International 20%.
June 2009
The Spanish branch was relocated from Barcelona to Madrid.
January 2005
Summit Pharma Europe S.p.A. Merged into Summit Pharmaceuticals Europe Ltd.
March 2002
Barcelona branch was opened. A spin out from SC Spain.
September 2001
Summit Pharmaceuticals Europe Ltd. was established in London, spinning out the Pharma business from Sumitomo Corporation Europe and Summit Chemicals Europe.
January 2000
Summit Pharma Italia S.r.l. Was renamed as Summit Pharma Europe S.p.A.
January 1997
Summit Pharma Italia S.r.l. Was established in Milan, spinning out the Pharma business from Sumitomo Corporation Italy.
